Actress Christina Applegate announced that she has been misdiagnosed with multiple sclerosis (MS), a revelation made during a recent podcast interview. She stated, “I’m back at square one,” expressing her disappointment after doctors failed to identify the cause of her ongoing symptoms.
This misdiagnosis has sparked discussions about the challenges of accurately diagnosing MS, which affects nearly one million Americans. Experts warn that around 15 percent of MS diagnoses may be incorrect, reflecting the complexities involved in identifying the disease.
Dr. Anna Shah, a neurologist at UCHealth University of Colorado Hospital, noted that diagnosing MS is particularly tricky because its symptoms—such as fatigue, numbness, and vision changes—overlap with various other medical issues. While a diagnosis usually involves MRIs and neurological exams, there is no single definitive test for MS.
Misinformation in initial diagnosis can lead to significant risks for patients. Treatments for MS often adjust or suppress immune activity, which can expose patients to infections and other complications. Dr. Shah emphasized the potential dangers of unnecessary medications for those misdiagnosed.
Marissa Poppens, a patient with MS, shared her experience living with the unpredictable disease since her diagnosis in 2015. She reported feeling the constant burden of uncertainty regarding her health and the challenges in securing treatment. Poppens highlighted the importance of confirming a diagnosis with specialists before beginning any long-term medication.
Experts recommend seeking a second opinion from a neurologist specializing in MS if there are uncertainties about a diagnosis. This is especially critical before starting medications that may alter immune system function.
The misdiagnosis raises important questions regarding the standards of care and the need for improved diagnostic criteria, which could help reduce the incidence of incorrect diagnoses in the future.
